Pharmacokinetics of Clodronate after Single Intravenous, Intramuscular and Subcutaneous Injections in Rats
- 1 November 1991
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 69 (5) , 365-368
- https://doi.org/10.1111/j.1600-0773.1991.tb01312.x
Abstract
The pharmacokinetics of clodronate was studied in rats after single intravenous, intramuscular and subcutaneous doses of a mixture of unlabelled and 14C-labelled disodium clodronate (25 mg/5 muCi/kg). The peak clodronate concentration in plasma was reached within 5 min., and the drug was eliminated with a half-life of about 1.5 hr regardless of administration route. Bioavailabilities after intramuscular and subcutaneous administration were 105% and 89%, respectively. During the 72 hr collection period, the mean share of clodronate recovered from the urine was about 53% of the dose regardless of administration route. Most of the drug was excreted during the first 24 hr. The amount of clodronate in bone (femur) was 186 micrograms/g tissue at 2 hr after intravenous administration, 188 micrograms/g after intramuscular administration and 157 micrograms/g after subcutaneous administration. It is concluded that absorption of clodronate after intramuscular and subcutaneous administration is rapid and good, and that the concentrations of the drug in bone after 2 hr are about the same as after intravenous administration.Keywords
This publication has 18 references indexed in Scilit:
- Disodium clodronate concentrations in serum, urine and bone after single and repeated subcutaneous administration in rabbitsEuropean Journal of Pharmacology, 1990
- The tissue distribution of clodronate (dichloromethylene bisphosphonate) in mice. The effects of vehicle and the route of administrationEuropean Journal of Drug Metabolism and Pharmacokinetics, 1990
- Comparison of the Distribution of Three Bisphosphonates in MiceBasic & Clinical Pharmacology & Toxicology, 1990
- LONG-TERM EFFECTS OF PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CL2MBP) ON BONE DISEASE OF MYELOMA PATIENTS TREATED WITH CHEMOTHERAPYHematological Oncology, 1990
- Treatment of painful bone lesions and hypercalcemiaEuropean Journal of Haematology, 1989
- Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronateBone, 1988
- A One Year Follow‐Up Study of the Distribution of 14C‐Clodronate in Mice and RatsBasic & Clinical Pharmacology & Toxicology, 1988
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEThe Lancet, 1980
- ESTRIP, a BASIC Computer Program for Obtaining Initial Polyexponential Parameter EstimatesJournal of Pharmaceutical Sciences, 1978